Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer
Biomaterials, Volume 277, October 2021, 121105 | https://doi.org/10.1016/j.biomaterials.2021.121105